World Health Organization (WHO) Recommended Two new drugs to fight COVID-19 infection.
The first new drug recommended for critical cases of COVID-19 is baricitinib, an oral medication that suppresses the immune system when overstimulated.
The World Health Organization recommends that baricitinib be given with corticosteroids.
The second medication to be used for mild cases where a person would have a high chance of being hospitalized is sotrofimab, a monoclonal antibody drug.
This should be given to individuals who are not immunized, are older, have compromised immune systems, or are obese, according to the World Health Organization.
“The extent to which these medicines can save lives depends on their widespread availability and affordability,” the World Health Organization said in its statement.
The recommendations come as concerns emerge that current COVID-19 treatments will not be effective against the omicron variant.
The two drugs were also invited on Friday to undergo the World Health Organization’s prequalification module, which “evaluates the quality, efficacy and safety of priority health products to increase access in low-income countries.”
The World Health Organization recommended the two drugs after evaluating evidence collected in seven trials examining 4,000 mild, severe and critical COVID-19 cases.
The US Food and Drug Administration has already approved baricitinib and sotrovimab for emergency use.
The World Health Organization has recommended against ruxolitinib and tofacitinib because of their uncertain effects.